All In MedTech

Device Trial Radar · NCT05883436

Investigation of DEXA-C Anterior Cervical Interbody System

A Prospective, Multi-Center Investigation of the DEXA- C Anterior Cervical Interbody System

Last checked: Nov 20, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

71

Actual

Start

Feb 22, 2023

Primary completion

Dec 31, 2026

Study completion Feb 22, 2027

Sponsor

Lead sponsor
Aurora Spine and PainNot on our public-company list
Sponsor type
Industry
First posted
Jun 1, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

FDA Cleared interbody product for the cervical spine, designed to match a patients DEXA scan for increase in fusion rate.

Conditions

  • Degenerative Disc Disease

Interventions

  • DEXA-C Cervical Interbody SystemDevice

    The Dexa-C Cervical Interbody System is intended for use on patients who require anterior cervical discectomy and fusion surgery. The system implants an interbody spacer(s) into the cervical intervertebral body space(s) to stabilize and fuse the level(s). Allograft will be used in the spacer and the spinal segment(s) are fixed with an anterior cervical plate

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Fusion AssesmentTime frame: 12 months

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • UCI Center for Clinical Research

    Orange, California

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.